Skip to main content
. 2021 Sep 10;16(9):e0257353. doi: 10.1371/journal.pone.0257353

Table 1. Patients’ features.

Category REM trial
Gender Male/Female 47/24
Age (years) Median (range) 59.6 (37–71)
Binet stage A 12
B 43
C 16
0 5
Rai stage I-II 47
III-IV 19
Copy number trisomy 12 10/71 (14.1%)
alterations del(13q)/normal 37/71 (52.1%)
del(17p) 3/71 (4.2%)
del(11q) 20/71 (28.2%)
IGHV Unmutated 44/67 (65.4%)
CD38 > 30% positive 36/69 (52,2%)
ZAP70 > 20% positive 39/66 (59%)
CD49d > 20% positive 27/68 (39.7%)